1. CX3CR1-Expressing Immune Cells Infiltrate the Tumor Microenvironment and Promote Radiation Resistance in a Mouse Model of Lung Cancer
    Tamar Ben-Mordechai et al, 2023, Cancers CrossRef
  2. Integrative network-based approaches identified systems-level molecular signatures associated with gallbladder cancer pathogenesis from gallstone diseases
    Nabanita Roy et al, 2022, Journal of Biosciences CrossRef
  3. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer
    Yuanyi Yue et al, 2022, Frontiers in Immunology CrossRef
  4. The promising role of miR-296 in human cancer
    Lingling Zhu et al, 2018, Pathology - Research and Practice CrossRef
  5. Fractalkine/CX3CR1 induces apoptosis resistance and proliferation through the activation of the AKT/NF‐κB cascade in pancreatic cancer cells
    Hui Wang et al, 2017, Cell Biochemistry and Function CrossRef
  6. Lymph‐circulating tumor cells show distinct properties to blood‐circulating tumor cells and are efficient metastatic precursors
    Sulma I. Mohammed et al, 2019, Molecular Oncology CrossRef
  7. Construction of a novel prognostic model in skin cutaneous melanoma based on chemokines-related gene signature
    Xiaoxia Ding et al, 2023, Scientific Reports CrossRef
  8. The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy
    Apoorvi Chaudhri et al, 2023, Frontiers in Immunology CrossRef
  9. ADAM17-regulated CX3CL1 expression produced by bone marrow endothelial cells promotes spinal metastasis from hepatocellular carcinoma
    Chi Sun et al, 2020, International Journal of Oncology CrossRef
  10. Effect of Genetic Modifications on Physical and Functional Titers of Adenoviral Cancer Gene Therapy Constructs
    Camilla Heiniö et al, 2019, Human Gene Therapy CrossRef
  11. CX3CL1 and its receptor CX3CR1 interact with RhoA signaling to induce paclitaxel resistance in gastric cancer
    Xiangyang Liu et al, 2024, Heliyon CrossRef
  12. Fractalkine/CX3CL1 in Neoplastic Processes
    Jan Korbecki et al, 2020, International Journal of Molecular Sciences CrossRef
  13. Involvement of CXC chemokines (CXCL1-CXCL17) in gastric cancer: Prognosis and therapeutic molecules
    Amin Ullah et al, 2024, Life Sciences CrossRef
  14. Differential impact of CX3CL1 on lung cancer prognosis in smokers and non‐smokers
    Ying‐Chieh Su et al, 2018, Molecular Carcinogenesis CrossRef
  15. CX3CL1 promotes cell sensitivity to ferroptosis and is associated with the tumor microenvironment in clear cell renal cell carcinoma
    Qiming Gong et al, 2022, BMC Cancer CrossRef

  16. Tumor-Draining Lymph Secretome En Route to the Regional Lymph Node in Breast Cancer Metastasis


    Sulma I Mohammed et al, 2020, Breast Cancer: Targets and Therapy CrossRef
  17. The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumor Metastatic Dissemination
    Marco Erreni et al, 2016, The Journal of Immunology CrossRef
  18. Selection of a new peptide homing SK‐BR‐3 breast cancer cells
    Ana Cláudia Pereira et al, 2021, Chemical Biology & Drug Design CrossRef
  19. Computerized Tomography Imaging Omics under Iterative Reconstruction Algorithm in Diagnosis of Gastric Cancer
    Chunfang Zhou et al, 2021, Scientific Programming CrossRef
  20. Involvement of CX3CR1+ cells appearing in the abdominal cavity in the immunosuppressive environment immediately after gastric cancer surgery
    Seiji Natsuki et al, 2024, World Journal of Surgical Oncology CrossRef
  21. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes
    László Bányai et al, 2021, eLife CrossRef
  22. Chemokine Receptor Antagonists: Role in Oncology
    Sean Kraus et al, 2021, Current Oncology Reports CrossRef
  23. Structure and Function of Ligand CX3CL1 and its Receptor CX3CR1 in Cancer
    Xinjie Lu, 2022, Current Medicinal Chemistry CrossRef
  24. CX3CL1 induces cell migration and invasion through ICAM‐1 expression in oral squamous cell carcinoma cells
    Chia‐Yu Wu et al, 2023, Journal of Cellular and Molecular Medicine CrossRef